​

SAB Biotherapeutics Ownership | Who Owns SAB Biotherapeutics?

OverviewForecastRevenueFinancialsChart

SAB Biotherapeutics Ownership Summary

SAB Biotherapeutics is owned by 5.11% institutional investors, and 94.89% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.52% of its assets in SAB Biotherapeutics shares.

SABS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSAB Biotherapeutics5.11%-94.89%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2023375.71%26,785,910591.27%58.65%1550.00%350.00%
Sep 30, 202335-7.89%3,874,859-2.09%712.46%10-16.67%2-50.00%
Jun 30, 2023382.70%3,957,7032.29%713.32%129.09%4-42.86%
Mar 31, 2023372.78%3,868,963-5.44%78.69%11-35.29%7-12.50%
Dec 31, 2022362.86%4,091,45923.76%915.92%1721.43%833.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv232.57K2.52%-
Vanguard Institutional Extnd Mkt Idx Tr42.64K0.46%-
Fidelity Extended Market Index42.24K0.46%1.39K
iShares Micro-Cap ETF14.37K0.16%-
Fidelity Series Total Market Index9.83K0.11%5.89K
Fidelity Total Market Index8.59K0.09%-
BlackRock Extended Equity Market K4.59K0.05%-2.00
Spartan Total Market Index Pool E2.84K0.03%-
Spartan Extended Market Index Pool E2.55K0.03%164.00
NT Ext Equity Mkt Idx Fd - NL2.25K0.02%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 07, 2023Sullivan Eddie Joe Chief Executive OfficerBuy$1.53K
Nov 30, 2023King Michael CHIEF FINANCIAL OFFICERBuy$4.50K
Nov 29, 2023Reich Samuel J Executive ChairmanBuy$9.84K
Sep 13, 2022HAMILTON CHRISTINE E Buy$7.30K
Sep 07, 2022Sullivan Eddie Joe CHIEF EXECUTIVE OFFICERBuy$10.32K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q43-
2023 Q2--

SABS Ownership FAQ

Who Owns SAB Biotherapeutics?

SAB Biotherapeutics shareholders are primarily institutional investors at 5.11%, followed by 0% insiders and 0% retail investors. The average institutional ownership in SAB Biotherapeutics's industry, Biotech Stocks , is 47.04%, which SAB Biotherapeutics falls below.

Does Blackrock own SAB Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of SAB Biotherapeutics.

Who is the top mutual fund holder of SAB Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SAB Biotherapeutics shares, with 2.52% of its total shares outstanding invested in 232.57K SAB Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools